TYRO3 and cancer: Consistent with the in vitro data, nuclear localisation of AXL and TYRO3 receptors was reported in cancer tissues, including schwannoma, radioresistant triple-negative breast cancer (AXL), CRC, and leiomyosarcoma (TYRO3) [102–105].